Anebulo Pharmaceuticals (ANEB)
(Delayed Data from NSDQ)
$2.33 USD
-0.07 (-2.92%)
Updated Jul 25, 2024 09:30 AM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ANEB 2.33 -0.07(-2.92%)
Will ANEB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ANEB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANEB
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
ANEB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
Other News for ANEB
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
Anebulo gets $1.9M cooperative grant award from NIDA for intravenous selonabant
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
Anebulo Pharmaceuticals GAAP EPS of -$0.06 beats by $0.06